Prospect Financial Services’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$693K Sell
16,485
-69
-0.4% -$2.2K 0.35% 57
2026
Q1
$437K Hold
16,554
0.27% 67
2025
Q4
$480K Buy
16,554
+2,640
+19% +$79.2K 0.28% 62
2025
Q3
$386K Buy
13,914
+600
+5% +$15.2K 0.22% 69
2025
Q2
$324K Sell
13,314
-340
-2% -$7.45K 0.2% 72
2025
Q1
$283K Buy
13,654
+1,273
+10% +$32K 0.16% 91
2024
Q4
$292K Hold
12,381
0.16% 86
2024
Q3
$317K Sell
12,381
-1,712
-12% -$43.6K 0.2% 74
2024
Q2
$331K Buy
14,093
+500
+4% +$12.6K 0.25% 57
2024
Q1
$391K Buy
13,593
+470
+4% +$14.1K 0.32% 51
2023
Q4
$431K Buy
+13,123
New +$357K 0.43% 42

Other funds holding ARKG

Prospect Financial Services's ARKG Position: Q2 2026 in Review

Prospect Financial Services reduced its ARK Genomic Revolution ETF (ARKG) stake by 0.42% in Q2 2026, selling an estimated $2.2K and leaving 16,485 shares worth $693K. The position accounts for 0.35% of the portfolio, ranked #57.

Prospect Financial Services first reported a position in ARKG in Q4 2023 and has held it in 11 quarters since. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Prospect Financial Services held 16,485 shares of ARK Genomic Revolution ETF worth $693K as of Q2 2026.
  • Prospect Financial Services sold 69 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $2.2K.
  • ARK Genomic Revolution ETF made up 0.35% of Prospect Financial Services's portfolio in Q2 2026, its #57 holding.
  • Prospect Financial Services first reported a position in ARK Genomic Revolution ETF in Q4 2023 and has held it in 11 quarters since.
  • 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Prospect Financial Services's 13F filing for Q2 2026, filed 6 Aug 2026.